Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Drug Metabolism And Disposition

• Publication date

  2004-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/DMD.32.4.398PMID 15039292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

  2009cited by this paper
• Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.

  2003cited by this paper
• Multiple cytochrome P450 enzymes responsible for the oxidative metabolism of the substituted (S)-3-phenylpiperidine, (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, in human liver microsomes.

  2002influential reference
• CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*

  2000cited by this paper
• Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations

  1999cited by this paper
• Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.

  1999cited by this paper
• Effects of the substituted (S)‐3‐phenylpiperidine (−)‐OSU6162 on PET measurements in subhuman primates: Evidence for tone‐dependent normalization of striatal dopaminergic activity

  1998cited by this paper
• Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

  1998cited by this paper
• (−)‐OSU 6162 inhibits levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

  1997cited by this paper
• Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.

  1996cited by this paper
• PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS

  1996cited by this paper
• An Overview of Current Cytochrome P450 Technology for Assessing the Safety and Efficacy of New Materials

  1996cited by this paper
• Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data.

  1995cited by this paper
• Applications and prospects for physiologically based pharmacokinetic (PB-PK) models involving pharmaceutical agents.

  1995cited by this paper
• Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

  1994cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993influential reference
• The allometric approach for interspecies scaling of pharmacokinetic parameters.

  1992cited by this paper
• Human cytochrome P-450 enzymes.

  1992cited by this paper
• Interspecies scaling in pharmacokinetics

  1991cited by this paper
• Interspecies Scaling of Clearance and Volume of Distribution Data for Five Therapeutic Proteins

  1991cited by this paper
• Interspecies scaling and comparisons in drug development and toxicokinetics.

  1990cited by this paper
• Interspecies Pharmacokinetic Scaling, Biological Design, and Neoteny

  1990cited by this paper
• The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids.

  1990influential reference
• Prediction of intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes.

  1990cited by this paper
• Interspecies pharmacokinetic scaling, biological design and neoteny

  1990cited by this paper
• Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancy

  1986influential reference
• A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations

  1986influential reference
• Man versus beast: pharmacokinetic scaling in mammals.

  1986influential reference
• Cytochrome P-450: Structure, Mechanism, and Biochemistry

  1986cited by this paper
• Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals

  1984cited by this paper
• Pharmacokinetics, Second Edition

  1982cited by this paper
• Bioavailability of Intramuscular Versus Oral Haloperidol in Schizophrenic Patients

  1982influential reference
• Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

  1980influential reference
• Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

  1977influential reference
• Advances in Drug Research

  1964cited by this paper

• The dopamine stabilizer (-)-OSU6162 attenuates levodopa-induced dyskinesia in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.

  2025cites this paper
• Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human.

  2017cites this paper
• Pharmacokinetics and allometric scaling of antimalarial drugs

  2015cites this paper
• Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model

  2011cites this paper
• TITLE: Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model versus Traditional One Compartment Model AUTHORS:

  2010cites this paper
• Microsoft Word-49434885-file00

  2010cites this paper
• Application of Stable Isotope Methodology in the Evaluation of the Pharmacokinetics of (S,S)-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine Hydrochloride in Rats

  2009influential citation
• Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance

  2007influential citation
• EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS

  2006cites this paper
• A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans.

  2004cites this paper